Related Experiment Video
Updated: Jun 10, 2026
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Identification of DeltaEF1 as a novel target that is negatively regulated by LMO2 in T-cell leukemia
Wei Sun1, Shuang Yang, Wenwen Shen
1Laboratory of Molecular Genetics, College of Medicine, Nankai University, Tianjin, China.
Abstract:
The lmo2 gene is a specific oncogene in T-cell leukemia, for its ectopic expression causes both increased pro-T-cell proliferation and differentiation arrest, leading to the onset of leukemia. Notably, DeltaEF1 (also known as ZEB1), a member of zinc finger-homeodomain family transcription factor, also exhibits crucial function in promoting T-cell differentiation. In this study, we found that DeltaEF1 was positively regulated by T-lineage-specific transcriptional regulator GATA3, while ectopically expressed LMO2 targeted to DeltaEF1 promoter by interaction with GATA3 and inhibited DeltaEF1 expression in transcriptional level. Moreover, LMO2 interacted with the N-terminal zinc finger domain of DeltaEF1 protein and inhibited its positive transcriptional regulatory function by this interaction. Taken together, our findings revealed that ectopically expressed LMO2 impaired the function of DeltaEF1 in both transcriptional and protein levels and identified DeltaEF1 as a novel pathogenic target of LMO2 in T-cell leukemia.
Insights
Ectopic LMO2 expression in T-cell leukemia impairs DeltaEF1 function at both gene and protein levels. This study identifies DeltaEF1 as a novel pathogenic target of LMO2 in leukemia development.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- The LMO2 gene is a known oncogene implicated in T-cell leukemia, promoting uncontrolled T-cell proliferation and blocking differentiation.
- DeltaEF1 (ZEB1), a transcription factor, is crucial for normal T-cell differentiation.
- Understanding the interplay between LMO2 and DeltaEF1 is key to T-cell leukemia pathogenesis.
Purpose of the Study:
- To investigate the regulatory relationship between the oncogene LMO2 and the T-cell differentiation factor DeltaEF1.
- To elucidate the mechanisms by which LMO2 affects DeltaEF1 expression and function.
- To identify DeltaEF1 as a potential therapeutic target in LMO2-driven T-cell leukemia.
Main Methods:
- Analysis of DeltaEF1 regulation by GATA3.
- Investigation of LMO2 interaction with the DeltaEF1 promoter and GATA3.
- Assessment of LMO2's effect on DeltaEF1 gene expression.
- Examination of LMO2's interaction with the DeltaEF1 protein and its functional consequences.
Main Results:
- DeltaEF1 is positively regulated by the T-lineage transcription factor GATA3.
- Ectopically expressed LMO2 interacts with GATA3 to inhibit DeltaEF1 expression at the transcriptional level.
- LMO2 directly interacts with the N-terminal zinc finger domain of DeltaEF1 protein.
- This interaction between LMO2 and DeltaEF1 protein inhibits DeltaEF1's transcriptional regulatory activity.
Conclusions:
- Ectopically expressed LMO2 disrupts DeltaEF1's function through both transcriptional inhibition and direct protein interaction.
- DeltaEF1 is identified as a novel pathogenic target of LMO2 in the context of T-cell leukemia.
- These findings provide new insights into the molecular mechanisms of T-cell leukemia and potential therapeutic strategies targeting the LMO2-DeltaEF1 axis.
